Nine reports of tumors in children treated with Novartis' spinal muscular atrophy (SMA) gene therapy Zolgensma raise new ...

Dutch biotech Anaheim Bio, a spin-out of BioMarin-acquired Alesta Therapeutics, has launched with an oversubscribed €40 ...

The Mainz-based vaccine developer is making progress in its transformation into an oncology company. But its quarterly report ...

University of Oxford spinout Alethio Therapeutics has raised $90 million (about €80 million) to take its G6B-targeting ...

Boehringer is turning to China for cancer research in a multibillion-dollar deal with Sino Biopharmaceutical. Six preclinical ...

French pharmaceutical group Servier has suffered a major setback just four months after completing its $1.55 billion upfront acquisition of Edgewise Therapeutics' muscular dystrophy business.

As advanced therapies and vaccines reshape healthcare, Wacker ­Biotech is emerging as a CDMO partner of choice. With decades ...

Bayer brings sevabertinib into the first-line setting in China — but Boehringer is already there: With the approval of ...

Denmark's Genmab said adding its bispecific antibody petosemtamab to MSD's Keytruda (pembrolizumab) cut the risk of death by ...

Swiss pharma group Ferring Pharmaceuticals has agreed to acquire New York-based Gameto for up to $1.3825 billion (€1.24 ...

Swedish biotech Alligator Bioscience has agreed to sell its CD40-targeting cancer immunotherapy mitazalimab to Canadian drug ...

Congress is one of the biggest events on the cancer research calendar, where clinical results can reshape treatment decisions ...